Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Watchlist
Price: 15.47 EUR 0.32% Market Closed
Market Cap: 982.7m EUR

Eckert & Ziegler Strahlen und Medizintechnik AG
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Eckert & Ziegler Strahlen und Medizintechnik AG
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Cash from Operating Activities
€66.5m
CAGR 3-Years
32%
CAGR 5-Years
19%
CAGR 10-Years
15%
Carl Zeiss Meditec AG
XETRA:AFX
Cash from Operating Activities
€195.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stratec SE
XETRA:SBS
Cash from Operating Activities
€21.8m
CAGR 3-Years
-15%
CAGR 5-Years
-6%
CAGR 10-Years
-5%
Siemens Healthineers AG
XETRA:SHL
Cash from Operating Activities
€3.5B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Cash from Operating Activities
€203m
CAGR 3-Years
N/A
CAGR 5-Years
2%
CAGR 10-Years
6%
Sartorius AG
XETRA:SRT
Cash from Operating Activities
€874.3m
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
20%
No Stocks Found

Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View

Market Cap
968m EUR
Industry
Health Care

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

EUZ Intrinsic Value
HIDDEN
Show

See Also

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Cash from Operating Activities?
Cash from Operating Activities
66.5m EUR

Based on the financial report for Sep 30, 2025, Eckert & Ziegler Strahlen und Medizintechnik AG's Cash from Operating Activities amounts to 66.5m EUR.

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
15%

Over the last year, the Cash from Operating Activities growth was 26%. The average annual Cash from Operating Activities growth rates for Eckert & Ziegler Strahlen und Medizintechnik AG have been 32% over the past three years , 19% over the past five years , and 15% over the past ten years .

Back to Top